Pharmaceutical and biotech stocks jumped Monday after investors reacted to the hantavirus outbreak linked to the Dutch-flagged cruise ship MV Hondius, according to CNBC.
Hantavirus cases spark surge in pharma and biotech stocks — here’s why https://t.co/vkZyq1ZT88
— CNBC International (@CNBCi) May 11, 2026
The World Health Organization first flagged the outbreak on May 2. Officials continue to describe the public health risk as low.
Stock Spike To Watch
• Moderna rose 7% after confirming early-stage hantavirus research with the US Army
• Inovio Pharmaceuticals climbed 11%, while Novavax gained 5% in early trading
• Analysts at Evercore said the rally appeared driven more by investor sentiment than long-term revenue expectations
Global Reactions So Far:
• President Donald Trump said the cruise ship situation appears “under control”
• WHO chief Tedros Adhanom Ghebreyesus said eight cases and three deaths have been reported so far
• Spanish authorities continue testing and monitoring passengers after the ship docked in Tenerife
Health officials say the Andes virus can spread between humans in rare cases. Authorities continue to stress that the overall risk to the public remains low.
Other Relevant Posts on 'X':
Hantaviruses are not naturally human infections.
— The Spectator (@spectator) May 11, 2026
The hosts of these viruses are small rodents which carry them harmlessly. When we’re unlucky enough to acquire one of these viruses, we’re effectively an incidental ‘dead-end’ host.
Being poorly adapted to these viruses the… pic.twitter.com/1Ol6q3xZK6
What we know so far about the Hantavirus outbreak:
— Mario Nawfal (@MarioNawfal) May 10, 2026
A deadly hantavirus strain hit the cruise ship MV Hondius. At least 3 people have died, with several confirmed cases. The ship, carrying passengers who were exposed in Argentina, has been stuck for nearly a month.
It’s now… https://t.co/XQFuMXNo03 pic.twitter.com/VGZnAx4p16
Dive Deeper

